Patents Assigned to SicClone Pharmaceuticals, Inc.
  • Method of administering a thymosin alpha 1 peptide
    Publication number: 20050049191
    Abstract: A Thymosin alpha 1 (TA1) peptide is administered to a patient in need of immune stimulation so as to substantially continuously maintain an immune stimulating-effective amount of the TA1 peptide in the patient. The administration method may be by continuous infusion.
    Type: Application
    Filed: November 1, 2002
    Publication date: March 3, 2005
    Applicant: SicClone Pharmaceuticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill